Research groups

The labs shaping drug & gene delivery

65 academic groups in 15 countries working on lipid nanoparticles, polymeric carriers, mRNA and CRISPR delivery and nanomedicine — with their principal investigators, research focus, selected papers and links to their labs.

North America

40 groups · Canada, USA

Cullis Lab

Pieter R. Cullis · Principal investigator

University of British Columbia · Vancouver, Canada

Focus: Lipid nanoparticle (LNP) technology for siRNA and mRNA therapeutics

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Lipid Membrane Structure and Behavior

h-index: 110
Publications: 417
Citations: 56,435

Selected papers

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugsNature Nanotechnology · 2019
The current landscape of nucleic acid therapeuticsNature Nanotechnology · 2021
Lipid Nanoparticle Systems for Enabling Gene TherapiesMolecular Therapy · 2017

Lab website ↗ORCID ↗All publications ↗

Shoichet Lab

Molly S. Shoichet · Principal investigator

University of Toronto · Toronto, Canada

Focus: Hydrogels and polymeric nanoparticles for drug and cell delivery

Hydrogels: synthesis, properties, applications
Tissue Engineering and Regenerative Medicine
Nerve injury and regeneration

h-index: 97
Publications: 437
Citations: 29,348

Selected papers

Microglia are an essential component of the neuroprotective scar that forms after spinal cord injuryNature Communications · 2019
A Hyaluronan-Based Injectable Hydrogel Improves the Survival and Integration of Stem Cell Progeny following TransplantationStem Cell Reports · 2015
Designer protein delivery: From natural to engineered affinity-controlled release systemsScience · 2016

Lab website ↗ORCID ↗All publications ↗

Chan Lab

Warren C. W. Chan · Principal investigator

University of Toronto · Toronto, Canada

Focus: Nanoparticle-biology interactions and delivery to solid tumours

Nanoparticle-Based Drug Delivery
Quantum Dots Synthesis And Properties
Nanoplatforms for cancer theranostics

h-index: 95
Publications: 256
Citations: 72,302

Selected papers

Analysis of nanoparticle delivery to tumoursNature Reviews Materials · 2016
The entry of nanoparticles into solid tumoursNature Materials · 2020
Nanoparticle–liver interactions: Cellular uptake and hepatobiliary eliminationJournal of Controlled Release · 2016

ORCID ↗All publications ↗

Photo: Rickinasia, CC BY-SA 4.0, via Wikimedia Commons

Allen Lab

Christine Allen · Principal investigator

University of Toronto · Toronto, Canada

Focus: Formulation of nanomedicines and data-driven drug delivery

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
Ultrasound and Hyperthermia Applications

h-index: 69
Publications: 306
Citations: 17,371

Selected papers

Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancementsAdvanced Drug Delivery Reviews · 2015
Machine learning directed drug formulation developmentAdvanced Drug Delivery Reviews · 2021
A translational framework to DELIVER nanomedicines to the clinicNature Nanotechnology · 2024

ORCID ↗All publications ↗

Langer Lab

Robert Langer · Principal investigator

Massachusetts Institute of Technology · Cambridge, MA, USA

Focus: Biomaterials, polymeric drug delivery and lipid nanoparticles for nucleic acids

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
Hydrogels: synthesis, properties, applications

h-index: 267
Publications: 1,872
Citations: 304,956

Selected papers

Engineering precision nanoparticles for drug deliveryNature Reviews Drug Discovery · 2020
Lipid nanoparticles for mRNA deliveryNature Reviews Materials · 2021
Delivery technologies for cancer immunotherapyNature Reviews Drug Discovery · 2019

Lab website ↗ORCID ↗All publications ↗

Photo: Teemu Rajala, CC BY 3.0, via Wikimedia Commons

Mirkin Group

Chad A. Mirkin · Principal investigator

Northwestern University · Evanston, USA

Focus: Spherical nucleic acids for gene regulation and immunotherapy

Advanced biosensing and bioanalysis techniques
Gold and Silver Nanoparticles Synthesis and Applications
Crystal structures of chemical compounds

h-index: 183
Publications: 1,701
Citations: 165,052

Selected papers

Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceChemical Reviews · 2015
Metal–Organic Framework NanoparticlesAdvanced Materials · 2018

ORCID ↗All publications ↗

Photo: Conrad Erb, CC BY-SA 3.0, via Wikimedia Commons

Lin Lab

Wenbin Lin · Principal investigator

University of Chicago · Chicago, USA

Focus: Nanoscale metal-organic frameworks for cancer therapy

Metal-Organic Frameworks: Synthesis and Applications
Crystal structures of chemical compounds
Nanoplatforms for cancer theranostics

h-index: 150
Publications: 794
Citations: 85,299

Selected papers

Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer ImmunotherapyAngewandte Chemie International Edition · 2018
Nanomedicine Applications of Hybrid Nanomaterials Built from Metal–Ligand Coordination Bonds: Nanoscale Metal–Organic Frameworks and Nanoscale Coordination PolymersChemical Reviews · 2015
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapyNature Communications · 2016

Lab website ↗ORCID ↗All publications ↗

Hubbell Lab

Jeffrey A. Hubbell · Principal investigator

University of Chicago · Chicago, USA

Focus: Immunoengineering and targeted nanomaterial delivery

Hydrogels: synthesis, properties, applications
Tissue Engineering and Regenerative Medicine
Immunotherapy and Immune Responses

h-index: 134
Publications: 746
Citations: 62,630

Selected papers

Engineering growth factors for regenerative medicine applicationsActa Biomaterialia · 2015
Extracellular matrix-inspired growth factor delivery systems for bone regenerationAdvanced Drug Delivery Reviews · 2015

ORCID ↗All publications ↗

Anderson Lab

Daniel G. Anderson · Principal investigator

Massachusetts Institute of Technology · Cambridge, MA, USA

Focus: Combinatorial lipid and polymer libraries for mRNA, siRNA and gene-editing delivery

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Tissue Engineering and Regenerative Medicine

h-index: 132
Publications: 421
Citations: 70,514

Selected papers

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA DeliveryMolecular Therapy · 2019
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivoNature Biotechnology · 2016
The clinical progress of mRNA vaccines and immunotherapiesNature Biotechnology · 2022

Lab website ↗ORCID ↗All publications ↗

Leong Lab

Kam W. Leong · Principal investigator

Columbia University · New York, USA

Focus: Non-viral gene editing delivery and nanomaterials for inflammation

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 132
Publications: 768
Citations: 62,876

Selected papers

Advanced drug delivery systems and artificial skin grafts for skin wound healingAdvanced Drug Delivery Reviews · 2018
Design of therapeutic biomaterials to control inflammationNature Reviews Materials · 2022
Bioinspired Diselenide‐Bridged Mesoporous Silica Nanoparticles for Dual‐Responsive Protein DeliveryAdvanced Materials · 2018

ORCID ↗All publications ↗

Huang Lab

Leaf Huang · Principal investigator

University of North Carolina at Chapel Hill · Chapel Hill, USA

Focus: Lipid-calcium-phosphate nanoparticles and tumour immunotherapy delivery

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Immunotherapy and Immune Responses

h-index: 131
Publications: 714
Citations: 59,601

Selected papers

mRNA vaccine for cancer immunotherapyMolecular Cancer · 2021
Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer ChemotherapyNano Letters · 2016
Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular CarcinomaACS Nano · 2020

ORCID ↗All publications ↗

Mitragotri Lab

Samir Mitragotri · Principal investigator

Harvard University · Cambridge, MA, USA

Focus: Cell-hitchhiking carriers, transdermal and oral drug delivery

Advanced Drug Delivery Systems
Advancements in Transdermal Drug Delivery
Nanoparticle-Based Drug Delivery

h-index: 126
Publications: 439
Citations: 65,370

Selected papers

Nanoparticles in the clinic: An updateBioengineering & Translational Medicine · 2019
The evolution of commercial drug delivery technologiesNature Biomedical Engineering · 2021
Nanoparticles in the clinicBioengineering & Translational Medicine · 2016

Lab website ↗ORCID ↗All publications ↗

Photo: Ian Barin, CC BY-SA 3.0, via Wikimedia Commons

Hammond Lab

Paula T. Hammond · Principal investigator

Massachusetts Institute of Technology · Cambridge, MA, USA

Focus: Layer-by-layer nanoparticles for targeted drug and siRNA delivery to tumours

Nanoparticle-Based Drug Delivery
Polymer Surface Interaction Studies
RNA Interference and Gene Delivery

h-index: 120
Publications: 899
Citations: 47,238

Selected papers

Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticlesNature Communications · 2018
Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritisScience Translational Medicine · 2018

Lab website ↗ORCID ↗All publications ↗

Photo: The White House, Public domain, via Wikimedia Commons

Davis Lab

Mark E. Davis · Principal investigator

California Institute of Technology · Pasadena, USA

Focus: Cyclodextrin-based polymer nanoparticles and targeted siRNA delivery

Zeolite Catalysis and Synthesis
Chemical Synthesis and Characterization
Mesoporous Materials and Catalysis

h-index: 120
Publications: 598
Citations: 63,673

Selected papers

Clinical experiences with systemically administered siRNA-based therapeutics in cancerNature Reviews Drug Discovery · 2015
Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle coreProceedings of the National Academy of Sciences · 2015
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosingProceedings of the National Academy of Sciences · 2016

ORCID ↗All publications ↗

Peppas Lab

Nicholas A. Peppas · Principal investigator

The University of Texas at Austin · Austin, USA

Focus: Intelligent hydrogels and oral protein/drug delivery

Hydrogels: synthesis, properties, applications
Advanced Drug Delivery Systems
Nanoparticle-Based Drug Delivery

h-index: 116
Publications: 608
Citations: 82,191

Selected papers

Engineering precision nanoparticles for drug deliveryNature Reviews Drug Discovery · 2020
Quantum dots in biomedical applicationsActa Biomaterialia · 2019
Bone tissue engineering via growth factor delivery: from scaffolds to complex matricesRegenerative Biomaterials · 2018

ORCID ↗All publications ↗

Photo: Apwebmaster, CC BY-SA 3.0, via Wikimedia Commons

Kabanov Lab

Alexander V. Kabanov · Principal investigator

University of North Carolina at Chapel Hill · Chapel Hill, USA

Focus: Polymeric micelles, polyion complexes and exosome-based delivery

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 108
Publications: 624
Citations: 44,507

Selected papers

Exosomes as drug delivery vehicles for Parkinson's disease therapyJournal of Controlled Release · 2015
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cellsNanomedicine Nanotechnology Biology and Medicine · 2015
Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approvalAdvanced Drug Delivery Reviews · 2020

Lab website ↗ORCID ↗All publications ↗

Photo: Lacyhaviz, CC BY-SA 4.0, via Wikimedia Commons

Irvine Lab

Darrell J. Irvine · Principal investigator

Massachusetts Institute of Technology · Cambridge, MA, USA

Focus: Nanoparticle vaccines and immunotherapy delivery

Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
T-cell and B-cell Immunology

h-index: 108
Publications: 554
Citations: 39,827

Selected papers

Enhancing cancer immunotherapy with nanomedicineNature reviews. Immunology · 2020
Synthetic Nanoparticles for Vaccines and ImmunotherapyChemical Reviews · 2015
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug deliveryNature Biotechnology · 2018

ORCID ↗All publications ↗

Mahmoudi Lab

Morteza Mahmoudi · Principal investigator

Michigan State University · East Lansing, USA

Focus: Protein corona and nanomedicine safety

Nanoparticle-Based Drug Delivery
Nanoparticles: synthesis and applications
Characterization and Applications of Magnetic Nanoparticles

h-index: 106
Publications: 468
Citations: 70,833

Selected papers

Cellular uptake of nanoparticles: journey inside the cellChemical Society Reviews · 2017
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissuesNature Nanotechnology · 2016
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokineticsNature Communications · 2017

ORCID ↗All publications ↗

Amiji Lab

Mansoor M. Amiji · Principal investigator

Northeastern University · Boston, USA

Focus: Multifunctional nanoemulsions and nanoparticles for drug and gene delivery

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
RNA Interference and Gene Delivery

h-index: 99
Publications: 461
Citations: 31,599

Selected papers

Exosome mediated communication within the tumor microenvironmentJournal of Controlled Release · 2015
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicineJournal of drug targeting · 2015
Local Immunomodulation Using an Adhesive Hydrogel Loaded with miRNA‐Laden Nanoparticles Promotes Wound HealingSmall · 2019

Lab website ↗ORCID ↗All publications ↗

Saltzman Lab

W. Mark Saltzman · Principal investigator

Yale University · New Haven, USA

Focus: Polymer nanoparticles for gene editing and drug delivery

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
RNA Interference and Gene Delivery

h-index: 98
Publications: 541
Citations: 31,042

Selected papers

A holistic approach to targeting disease with polymeric nanoparticlesNature Reviews Drug Discovery · 2015
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecovirusesScience · 2022
A sunblock based on bioadhesive nanoparticlesNature Materials · 2015

Lab website ↗ORCID ↗All publications ↗

Weissman Lab

Drew Weissman · Principal investigator

University of Pennsylvania · Philadelphia, USA

Focus: Nucleoside-modified mRNA and LNP vaccines and therapeutics

RNA Interference and Gene Delivery
Immunotherapy and Immune Responses
Nanoparticle-Based Drug Delivery

h-index: 93
Publications: 413
Citations: 42,757

Selected papers

mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery · 2018
mRNA vaccines for infectious diseases: principles, delivery and clinical translationNature Reviews Drug Discovery · 2021
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesJournal of Controlled Release · 2015

Lab website ↗ORCID ↗All publications ↗

Photo: Thorne Media at 0:08 and 0:28, cropped, brightened, CC BY 3.0, via Wikimedia Commons

DeSimone Lab

Joseph M. DeSimone · Principal investigator

Stanford University · Stanford, USA

Focus: PRINT particle engineering and precision-shaped nanocarriers

Phase Equilibria and Thermodynamics
Nanoparticle-Based Drug Delivery
Advanced Polymer Synthesis and Characterization

h-index: 92
Publications: 685
Citations: 36,708

Selected papers

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapyNature Nanotechnology · 2017
Single-Step Fabrication of Computationally Designed Microneedles by Continuous Liquid Interface ProductionPLoS ONE · 2016
Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and LocationNano Letters · 2017

Lab website ↗ORCID ↗All publications ↗

Photo: Douglas A. Lockard, CC BY-SA 3.0, via Wikimedia Commons

Gong Lab

Shaoqin Gong · Principal investigator

University of Wisconsin–Madison · Madison, USA

Focus: Nanocapsules for CRISPR genome-editing delivery

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Dendrimers and Hyperbranched Polymers

h-index: 82
Publications: 247
Citations: 18,815

Selected papers

A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editingNature Nanotechnology · 2019
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated NanoparticlesAdvanced Materials · 2019

ORCID ↗All publications ↗

Torchilin Lab

Vladimir P. Torchilin · Principal investigator

Northeastern University · Boston, USA

Focus: Liposomes, micelles and stimuli-sensitive pharmaceutical nanocarriers

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 78
Publications: 269
Citations: 40,796

Selected papers

New Developments in Liposomal Drug DeliveryChemical Reviews · 2015
Recent advancements in liposome technologyAdvanced Drug Delivery Reviews · 2020
Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastomaJournal of Controlled Release · 2018

All publications ↗

Mao Lab

Hai-Quan Mao · Principal investigator

Johns Hopkins University · Baltimore, USA

Focus: Scalable nanoparticle manufacturing (flash nanocomplexation) for gene delivery

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Tissue Engineering and Regenerative Medicine

h-index: 77
Publications: 357
Citations: 19,184

Selected papers

Control of polymeric nanoparticle size to improve therapeutic deliveryJournal of Controlled Release · 2015
Payload distribution and capacity of mRNA lipid nanoparticlesNature Communications · 2022
Effects of Mesenchymal Stem Cell‐Derived Paracrine Signals and Their Delivery StrategiesAdvanced Healthcare Materials · 2021

ORCID ↗All publications ↗

Gao Lab

Jinming Gao · Principal investigator

The University of Texas Southwestern Medical Center · Dallas, USA

Focus: pH-sensitive ultra-pH nanoparticles for imaging and immunotherapy

Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Advanced Drug Delivery Systems

h-index: 75
Publications: 231
Citations: 25,673

Selected papers

A STING-activating nanovaccine for cancer immunotherapyNature Nanotechnology · 2017
Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobesAdvanced Drug Delivery Reviews · 2016
Cooperativity Principles in Self-Assembled NanomedicineChemical Reviews · 2018

Lab website ↗ORCID ↗All publications ↗

Steinmetz Lab

Nicole F. Steinmetz · Principal investigator

University of California, San Diego · San Diego, USA

Focus: Plant virus nanoparticles for vaccines and drug delivery

Nanoparticle-Based Drug Delivery
Immunotherapy and Immune Responses
Transgenic Plants and Applications

h-index: 73
Publications: 399
Citations: 17,414

Selected papers

In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancerNature Nanotechnology · 2015
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applicationsAdvanced Drug Delivery Reviews · 2020
Design of virus-based nanomaterials for medicine, biotechnology, and energyChemical Society Reviews · 2016

ORCID ↗All publications ↗

Photo: UC San Diego Jacobs School of Engineering, CC BY 2.0, via Wikimedia Commons

Shi Lab

Jinjun Shi · Principal investigator

Brigham and Women's Hospital · Boston, USA

Focus: mRNA nanomedicine for cancer and tumour-suppressor restoration

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Nanoplatforms for cancer theranostics

h-index: 72
Publications: 181
Citations: 26,000

Selected papers

Cancer nanomedicine: progress, challenges and opportunitiesNature reviews. Cancer · 2016
Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer TheranosticsAdvanced Materials · 2016
Nanodelivery of nucleic acidsNature Reviews Methods Primers · 2022

ORCID ↗All publications ↗

Ghandehari Lab

Hamidreza Ghandehari · Principal investigator

University of Utah · Salt Lake City, USA

Focus: Recombinant polymers and silica nanoparticles for drug delivery

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
Hydrogels: synthesis, properties, applications

h-index: 70
Publications: 262
Citations: 16,509

Selected papers

Nanoparticle uptake: The phagocyte problemNano Today · 2015
Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applicationsAdvanced Drug Delivery Reviews · 2019
Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expressionJournal of Controlled Release · 2017

ORCID ↗All publications ↗

Mitchell Lab

Michael J. Mitchell · Principal investigator

University of Pennsylvania · Philadelphia, USA

Focus: Ionisable lipid nanoparticles for in vivo CAR-T, placenta and blood-cell delivery

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Immunotherapy and Immune Responses

h-index: 68
Publications: 243
Citations: 25,403

Selected papers

Engineering precision nanoparticles for drug deliveryNature Reviews Drug Discovery · 2020
Delivery technologies for cancer immunotherapyNature Reviews Drug Discovery · 2019
Advances in Biomaterials for Drug DeliveryAdvanced Materials · 2018

Lab website ↗ORCID ↗All publications ↗

Green Lab

Jordan J. Green · Principal investigator

Johns Hopkins University · Baltimore, USA

Focus: Biodegradable poly(beta-amino ester) nanoparticles for gene delivery and immunoengineering

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Immunotherapy and Immune Responses

h-index: 68
Publications: 330
Citations: 15,623

Selected papers

Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid DeliveryAdvanced Materials · 2019
Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in VivoACS Nano · 2015

Lab website ↗ORCID ↗All publications ↗

Xu Lab

Qiaobing Xu · Principal investigator

Tufts University · Medford, MA, USA

Focus: Combinatorial lipidoids for protein, mRNA and CRISPR/Cas9 delivery

Electrocatalysts for Energy Conversion
Advanced Photocatalysis Techniques
Supercapacitor Materials and Fabrication

h-index: 66
Publications: 189
Citations: 15,594

Selected papers

Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticlesProceedings of the National Academy of Sciences · 2016
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agentsNature · 2017
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosisProceedings of the National Academy of Sciences · 2022

ORCID ↗All publications ↗

Murthy Lab

Niren Murthy · Principal investigator

University of California, Berkeley · Berkeley, USA

Focus: CRISPR-Cas9 delivery with nanoparticles and engineered proteins

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 62
Publications: 209
Citations: 16,628

Selected papers

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repairNature Biomedical Engineering · 2017
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behavioursNature Biomedical Engineering · 2018

Lab website ↗ORCID ↗All publications ↗

Pun Lab

Suzie H. Pun · Principal investigator

University of Washington · Seattle, USA

Focus: Peptide and polymer materials for nucleic acid and immunomodulatory delivery

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Dendrimers and Hyperbranched Polymers

h-index: 61
Publications: 210
Citations: 15,688

Selected papers

Drug delivery to the central nervous systemNature Reviews Materials · 2021
Cationic polymers for non-viral gene delivery to human T cellsJournal of Controlled Release · 2018

Lab website ↗ORCID ↗All publications ↗

Siegwart Lab

Daniel J. Siegwart · Principal investigator

The University of Texas Southwestern Medical Center · Dallas, USA

Focus: Selective organ targeting (SORT) LNPs and dendrimer-based RNA/CRISPR delivery

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Dendrimers and Hyperbranched Polymers

h-index: 58
Publications: 139
Citations: 17,594

Selected papers

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editingNature Nanotechnology · 2020
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticlesProceedings of the National Academy of Sciences · 2021
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugsNature Reviews Materials · 2023

Lab website ↗ORCID ↗All publications ↗

Dong Lab

Yizhou Dong · Principal investigator

Icahn School of Medicine at Mount Sinai · New York, USA

Focus: Lipid-like nanomaterials for mRNA therapeutics and CRISPR delivery

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
CRISPR and Genetic Engineering

h-index: 57
Publications: 166
Citations: 15,979

Selected papers

Lipid nanoparticles for mRNA deliveryNature Reviews Materials · 2021
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivoNature Biotechnology · 2016
Lipids and Lipid Derivatives for RNA DeliveryChemical Reviews · 2021

ORCID ↗All publications ↗

Veiseh Lab

Omid Veiseh · Principal investigator

Rice University · Houston, USA

Focus: Biomaterials for implanted cell therapies and protein delivery

Nanoparticle-Based Drug Delivery
Tissue Engineering and Regenerative Medicine
Immunotherapy and Immune Responses

h-index: 52
Publications: 182
Citations: 16,048

Selected papers

Self-assembled hydrogels utilizing polymer–nanoparticle interactionsNature Communications · 2015
Recent Advancements of Magnetic Nanomaterials in Cancer TherapyPharmaceutics · 2020
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road aheadNature Reviews Endocrinology · 2024

Lab website ↗ORCID ↗All publications ↗

Dahlman Lab

James E. Dahlman · Principal investigator

Georgia Institute of Technology · Atlanta, USA

Focus: DNA-barcoded high-throughput screening of LNPs in vivo

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Advancements in Transdermal Drug Delivery

h-index: 51
Publications: 116
Citations: 13,547

Selected papers

Drug delivery systems for RNA therapeuticsNature Reviews Genetics · 2022
Emerging Frontiers in Drug DeliveryJournal of the American Chemical Society · 2016
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungsNature Biomedical Engineering · 2021

Lab website ↗ORCID ↗All publications ↗

Sahay Lab

Gaurav Sahay · Principal investigator

Oregon State University · Portland, USA

Focus: LNP intracellular trafficking and mRNA delivery to lung and eye

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems

h-index: 48
Publications: 925
Citations: 16,443

Selected papers

In vitro and ex vivo strategies for intracellular deliveryNature · 2016
Chemistry of Lipid Nanoparticles for RNA DeliveryAccounts of Chemical Research · 2021
Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNANature Communications · 2020

Lab website ↗ORCID ↗All publications ↗

Whitehead Lab

Kathryn A. Whitehead · Principal investigator

Carnegie Mellon University · Pittsburgh, USA

Focus: Lipid nanoparticle design for mRNA and siRNA delivery, oral delivery

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems

h-index: 43
Publications: 111
Citations: 14,535

Selected papers

mRNA vaccines for infectious diseases: principles, delivery and clinical translationNature Reviews Drug Discovery · 2021
Tools for translation: non-viral materials for therapeutic mRNA deliveryNature Reviews Materials · 2017
Materials for oral delivery of proteins and peptidesNature Reviews Materials · 2019

Lab website ↗ORCID ↗All publications ↗

Europe

13 groups · Belgium, France, Germany, Netherlands, Spain, United Kingdom

Lab of General Biochemistry & Physical Pharmacy

Stefaan C. De Smedt · Principal investigator

Ghent University · Ghent, Belgium

Focus: Photothermal and nanoparticle-based intracellular delivery of nucleic acids

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems

h-index: 109
Publications: 616
Citations: 40,418

Selected papers

N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and miceJournal of Controlled Release · 2015

ORCID ↗All publications ↗

Braeckmans Lab

Kevin Braeckmans · Principal investigator

Ghent University · Ghent, Belgium

Focus: Laser-induced photoporation and advanced microscopy of nanocarriers

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 79
Publications: 394
Citations: 21,219

Selected papers

The proton sponge hypothesis: Fable or fact?European Journal of Pharmaceutics and Biopharmaceutics · 2018
Photothermal nanofibres enable safe engineering of therapeutic cellsNature Nanotechnology · 2021

ORCID ↗All publications ↗

Couvreur Lab

Patrick Couvreur · Principal investigator

Université Paris-Saclay · Orsay, France

Focus: Squalene-based nanomedicines and biodegradable nanoparticles

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
RNA Interference and Gene Delivery

h-index: 122
Publications: 743
Citations: 72,025

Selected papers

Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in BiomedicineAdvanced Materials · 2018
Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applicationsChemical Society Reviews · 2022
Advanced nanomedicines for the treatment of inflammatory diseasesAdvanced Drug Delivery Reviews · 2020

Lab website ↗ORCID ↗All publications ↗

Lammers Lab

Twan Lammers · Principal investigator

RWTH Aachen University · Aachen, Germany

Focus: Tumour-targeted nanomedicine, EPR effect and image-guided drug delivery

Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Ultrasound and Hyperthermia Applications

h-index: 101
Publications: 458
Citations: 35,907

Selected papers

Tumor targeting via EPR: Strategies to enhance patient responsesAdvanced Drug Delivery Reviews · 2018
Smart cancer nanomedicineNature Nanotechnology · 2019
Challenges and strategies in anti-cancer nanomedicine development: An industry perspectiveAdvanced Drug Delivery Reviews · 2016

Lab website ↗ORCID ↗All publications ↗

Wagner Lab

Ernst Wagner · Principal investigator

Ludwig-Maximilians-Universität München · Munich, Germany

Focus: Sequence-defined oligoaminoamide carriers for non-viral nucleic acid delivery

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Dendrimers and Hyperbranched Polymers

h-index: 98
Publications: 663
Citations: 39,933

Selected papers

Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)Chemical Reviews · 2015
Imparting Functionality to MOF Nanoparticles by External Surface Selective Covalent Attachment of PolymersChemistry of Materials · 2016
Multifunctional Nanoparticles by Coordinative Self-Assembly of His-Tagged Units with Metal–Organic FrameworksJournal of the American Chemical Society · 2017

Lab website ↗ORCID ↗All publications ↗

Aigner Lab

Achim Aigner · Principal investigator

Leipzig University · Leipzig, Germany

Focus: Polyethylenimine-based siRNA delivery and RNAi therapy

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Dendrimers and Hyperbranched Polymers

h-index: 58
Publications: 293
Citations: 12,066

Selected papers

Therapeutic siRNA: State-of-the-Art and Future PerspectivesBioDrugs · 2022
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson’s DiseaseMolecular Therapy — Nucleic Acids · 2017
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer TreatmentPharmaceutics · 2021

ORCID ↗All publications ↗

Merkel Lab

Olivia M. Merkel · Principal investigator

Ludwig-Maximilians-Universität München · Munich, Germany

Focus: siRNA and mRNA pulmonary delivery with polymers and lipids

RNA Interference and Gene Delivery
Nanoparticle-Based Drug Delivery
Inhalation and Respiratory Drug Delivery

h-index: 51
Publications: 223
Citations: 7,932

Selected papers

Intranasal drug delivery: opportunities and toxicologic challenges during drug developmentDrug Delivery and Translational Research · 2021
Applications of polymer micelles for imaging and drug deliveryWiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 2015
Immunogenicity of Cas9 ProteinJournal of Pharmaceutical Sciences · 2019

ORCID ↗All publications ↗

Storm Lab

Gert Storm · Principal investigator

Utrecht University · Utrecht, Netherlands

Focus: Liposomes and targeted nanomedicine

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 108
Publications: 511
Citations: 41,058

Selected papers

Challenges and strategies in anti-cancer nanomedicine development: An industry perspectiveAdvanced Drug Delivery Reviews · 2016
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and CommercializationFrontiers in Pharmacology · 2018
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and ProspectsChemical Reviews · 2015

Lab website ↗ORCID ↗All publications ↗

Santos Lab

Hélder A. Santos · Principal investigator

University of Groningen · Groningen, Netherlands

Focus: Porous silicon and microfluidics-produced nanocarriers

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
Nanoplatforms for cancer theranostics

h-index: 100
Publications: 623
Citations: 31,103

Selected papers

Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applicationsProgress in Materials Science · 2017
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapyNature Communications · 2019
The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative propertiesChemical Society Reviews · 2020

Lab website ↗ORCID ↗All publications ↗

Schiffelers Lab

Raymond M. Schiffelers · Principal investigator

University Medical Center Utrecht · Utrecht, Netherlands

Focus: Extracellular vesicles and liposomes as RNA and drug carriers

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Extracellular vesicles in disease

h-index: 86
Publications: 350
Citations: 42,852

Selected papers

Extracellular vesicles for drug deliveryAdvanced Drug Delivery Reviews · 2016
Extracellular vesicles as drug delivery systems: Why and how?Advanced Drug Delivery Reviews · 2020
In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic BehaviorCell · 2015

Lab website ↗ORCID ↗All publications ↗

Alonso Lab

María José Alonso · Principal investigator

University of Santiago de Compostela · Santiago de Compostela, Spain

Focus: Polymeric nanocarriers for transmucosal drug and vaccine delivery

Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems
RNA Interference and Gene Delivery

h-index: 97
Publications: 399
Citations: 32,904

Selected papers

A translational framework to DELIVER nanomedicines to the clinicNature Nanotechnology · 2024
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trialsAdvanced Drug Delivery Reviews · 2016
Lipid-based nanocarriers for oral peptide deliveryAdvanced Drug Delivery Reviews · 2016

ORCID ↗All publications ↗

Photo: Real Academia Galega da Ciencia (legal disclaimer), CC BY 4.0, via Wikimedia Commons

Stevens Group

Molly M. Stevens · Principal investigator

University of Oxford · Oxford, United Kingdom

Focus: Bioinspired materials, nanoparticle biosensing and RNA delivery

Bone Tissue Engineering Materials
Tissue Engineering and Regenerative Medicine
Hydrogels: synthesis, properties, applications

h-index: 119
Publications: 683
Citations: 54,630

Selected papers

Re-Engineering Extracellular Vesicles as Smart Nanoscale TherapeuticsACS Nano · 2017
Cubosomes: The Next Generation of Smart Lipid Nanoparticles?Angewandte Chemie International Edition · 2018
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applicationsChemical Society Reviews · 2018

Lab website ↗ORCID ↗All publications ↗

Photo: Wikimedia Commons, CC0, via Wikimedia Commons

Nanomedicine Lab

Kostas Kostarelos · Principal investigator

University of Manchester · Manchester, United Kingdom

Focus: Carbon and 2D nanomaterials (graphene) for delivery and neurology

Graphene and Nanomaterials Applications
Nanoparticle-Based Drug Delivery
Graphene research and applications

h-index: 98
Publications: 457
Citations: 38,559

Selected papers

Nanocomposite Hydrogels: 3D Polymer–Nanoparticle Synergies for On-Demand Drug DeliveryACS Nano · 2015
Trends in Micro‐/Nanorobotics: Materials Development, Actuation, Localization, and System Integration for Biomedical ApplicationsAdvanced Materials · 2020

Lab website ↗ORCID ↗All publications ↗

Asia-Pacific

8 groups · Australia, China, Japan, Singapore, South Korea

Caruso Group

Frank Caruso · Principal investigator

University of Melbourne · Melbourne, Australia

Focus: Engineered particles, metal-phenolic networks and bio-nano interactions

Polymer Surface Interaction Studies
Nanoparticle-Based Drug Delivery
Advanced Drug Delivery Systems

h-index: 148
Publications: 863
Citations: 84,481

Selected papers

Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological DiseasesAdvanced Materials · 2018
A Decade of the Protein CoronaACS Nano · 2017
Metal-phenolic networks as a versatile platform to engineer nanomaterials and biointerfacesNano Today · 2016

ORCID ↗All publications ↗

Photo: Duncan.Hull, CC BY-SA 4.0, via Wikimedia Commons

Gu Lab

Zhen Gu · Principal investigator

Zhejiang University · Hangzhou, China

Focus: Bioresponsive and cell-based delivery systems, microneedles

Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Advanced Drug Delivery Systems

h-index: 122
Publications: 487
Citations: 50,492

Selected papers

Bioresponsive materialsNature Reviews Materials · 2016
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatmentNature Nanotechnology · 2018
Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin deliveryProceedings of the National Academy of Sciences · 2015

ORCID ↗All publications ↗

Liang Lab

Xing-Jie Liang · Principal investigator

National Center for Nanoscience and Technology · Beijing, China

Focus: Nanomedicine for overcoming drug resistance and gene delivery

Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
RNA Interference and Gene Delivery

h-index: 114
Publications: 657
Citations: 45,543

Selected papers

Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacyTheranostics · 2020
The challenge and prospect of mRNA therapeutics landscapeBiotechnology Advances · 2020

ORCID ↗All publications ↗

Kataoka Lab

Kazunori Kataoka · Principal investigator

Innovation Center of NanoMedicine · Kawasaki, Japan

Focus: Polymeric micelles and polyion complexes for drug and nucleic acid delivery

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Polymer Synthesis and Characterization

h-index: 155
Publications: 1,154
Citations: 91,609

Selected papers

Block Copolymer Micelles in Nanomedicine ApplicationsChemical Reviews · 2018
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repairNature Biomedical Engineering · 2017
Nanomaterial-based blood-brain-barrier (BBB) crossing strategiesBiomaterials · 2019

Lab website ↗ORCID ↗All publications ↗

Harashima Lab

Hideyoshi Harashima · Principal investigator

Hokkaido University · Sapporo, Japan

Focus: Multifunctional envelope-type nano devices (MEND) and pH-sensitive lipids

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advancements in Transdermal Drug Delivery

h-index: 90
Publications: 686
Citations: 32,139

Selected papers

Clinical translation of nanomedicines: Challenges, opportunities, and keysAdvanced Drug Delivery Reviews · 2021
Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systemsAdvanced Drug Delivery Reviews · 2018
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activationJournal for ImmunoTherapy of Cancer · 2021

Lab website ↗ORCID ↗All publications ↗

Chen Lab

Xiaoyuan Chen · Principal investigator

National University of Singapore · Singapore, Singapore

Focus: Theranostic nanoparticles and molecular imaging-guided delivery

Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Radiopharmaceutical Chemistry and Applications

h-index: 120
Publications: 735
Citations: 63,059

Selected papers

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancerChemical Society Reviews · 2018
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapyChemical Society Reviews · 2016
Nanotechnology for Multimodal Synergistic Cancer TherapyChemical Reviews · 2017

Lab website ↗ORCID ↗All publications ↗

Hyeon Group

Taeghwan Hyeon · Principal investigator

Seoul National University · Seoul, South Korea

Focus: Inorganic nanoparticle synthesis for biomedical applications

Quantum Dots Synthesis And Properties
Nanoparticle-Based Drug Delivery
Mesoporous Materials and Catalysis

h-index: 175
Publications: 713
Citations: 114,881

Selected papers

The surface science of nanocrystalsNature Materials · 2016
Wearable/disposable sweat-based glucose monitoring device with multistage transdermal drug delivery moduleScience Advances · 2017

Lab website ↗ORCID ↗All publications ↗

Photo: Alfred1221, CC BY-SA 3.0, via Wikimedia Commons

Kwon Lab

Ick Chan Kwon · Principal investigator

Korea Institute of Science and Technology · Seoul, South Korea

Focus: Tumour-targeting polymeric nanoparticles and imaging

Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Advanced Drug Delivery Systems

h-index: 112
Publications: 537
Citations: 41,933

Selected papers

Long-Circulating Au-TiO2Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of CancerNano Letters · 2016
Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor MicroenvironmentTheranostics · 2019
ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancerScientific Reports · 2016

ORCID ↗All publications ↗

Middle East

4 groups · Iran, Israel

Jaafari Lab

Mahmoud Reza Jaafari · Principal investigator

Mashhad University of Medical Sciences · Mashhad, Iran

Focus: Liposomal nanomedicines and nano-vaccines

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Immunotherapy and Immune Responses

h-index: 70
Publications: 452
Citations: 15,369

Selected papers

Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivoInternational Journal of Nanomedicine · 2018
Perspective of Fe3O4Nanoparticles Role in Biomedical ApplicationsBiochemistry Research International · 2016

ORCID ↗All publications ↗

Peer Lab

Dan Peer · Principal investigator

Tel Aviv University · Tel Aviv, Israel

Focus: Targeted LNPs for RNA therapeutics and leukocyte-directed delivery

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 69
Publications: 248
Citations: 26,093

Selected papers

Progress and challenges towards targeted delivery of cancer therapeuticsNature Communications · 2018
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyScience Advances · 2020
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticlesBioengineering & Translational Medicine · 2021

ORCID ↗All publications ↗

Photo: Tel Aviv University photographer, CC BY-SA 3.0, via Wikimedia Commons

Satchi-Fainaro Lab

Ronit Satchi-Fainaro · Principal investigator

Tel Aviv University · Tel Aviv, Israel

Focus: Polymer therapeutics and nanomedicines for cancer

Nanoparticle-Based Drug Delivery
Glioma Diagnosis and Treatment
Dendrimers and Hyperbranched Polymers

h-index: 62
Publications: 280
Citations: 10,986

Selected papers

Current hurdles to the translation of nanomedicines from bench to the clinicDrug Delivery and Translational Research · 2021
Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic TumorsACS Nano · 2019
Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapyJournal of Controlled Release · 2016

Lab website ↗ORCID ↗All publications ↗

Photo: Shani Evenstein (שני אבנשטיין), CC BY-SA 4.0, via Wikimedia Commons

Schroeder Lab

Avi Schroeder · Principal investigator

Technion – Israel Institute of Technology · Haifa, Israel

Focus: Nanoparticles with synthetic cells and personalised cancer nanomedicine

Nanoparticle-Based Drug Delivery
RNA Interference and Gene Delivery
Advanced Drug Delivery Systems

h-index: 48
Publications: 120
Citations: 12,431

Selected papers

Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systemsChemical Engineering Journal · 2018
Nanodelivery of nucleic acidsNature Reviews Methods Primers · 2022
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer MedicineAdvanced Materials · 2019

Lab website ↗ORCID ↗All publications ↗

This directory is an independent overview compiled from public sources. Brilliant Blue Biosciences is not affiliated with the groups listed. Publication counts, citations and h-index come from OpenAlex (October 2026) and may differ from other databases. Portraits are shown only where a freely licensed image exists. If you lead one of these groups and would like a correction, a photo or to be removed, please contact us.

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through GMP supply.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes, licensing and GMP supply.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.